NanoImaging Services Secures $12.19M in Series B Funding for Advancing Cryo-EM in Drug Development

NanoImaging Services (NIS), the industry leader in cryo-electron microscopy (cryo-EM), is excited to announce that it has successfully raised $12,190,000 in its latest funding round. This significant investment will be pivotal in further advancing its mission to provide unparalleled insight into biomolecular structures, facilitating every stage of the drug development process—from target identification to formulation and manufacturing. With the largest pool of cryo-EM scientists and the greatest number of transmission electron microscopes (TEM) in North America, NIS stands at the forefront of structural biology and nanoparticle characterization. The funding will support the enhancement of NIS’s state-of-the-art facilities and technology, allowing the company to expedite high-resolution data collection and single-particle analysis, with a remarkable average turnaround of just four weeks from sample to structure. Additionally, NIS aims to broaden its reach by making cryo-EM services more accessible to companies of varying sizes across the drug discovery pipeline. As the demand for innovative and life-changing therapeutics continues to grow, this funding will empower NIS to extend its R&D and GMP-compliant services, facilitating comprehensive morphology assessments that assess size, shape, uniformity, purity, and cargo encapsulation of nanoparticles. This infusion of capital not only reinforces NIS’s position as a leader in the field but also promises to usher in a new era of efficiencies and breakthroughs in drug development, benefiting patients and research institutions alike.